Avricore Health (TSE:AVCR) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Avricore Health Inc. has reported its first net profitability with a comprehensive income of $168,537 and a significant year-over-year revenue increase of 79% to $1,124,307 for Q1 2024. The company’s gross profit also soared by 130%, and its gross margin surpassed targets, hitting 43%. As it continues to expand its HealthTab™ network both domestically and internationally, Avricore is solidifying its position in the rapidly growing point-of-care testing market.
For further insights into TSE:AVCR stock, check out TipRanks’ Stock Analysis page.
